Table 5.
SUCRA values of seven treatment modalities under twelve endpoint outcomes.
| Treatments |
||||||||
|---|---|---|---|---|---|---|---|---|
| SUCRA values (%) | A | B | C | D | E | F | G | |
| Hematologic (all grades) | ||||||||
| Anemia | 44.6 | 75.2 | 43.2 | 92.4 | NR | NR | 45.0 | |
| Neutropenia | 47.0 | 74.2 | 45.6 | 91.8 | NR | NR | 40.4 | |
| Thrombocytopenia | 68.0 | 95.2 | 36.8 | 47.2 | NR | NR | 53.0 | |
| Hematologic (grade≥3) | ||||||||
| Anemia | 47.2 | 86.7 | 30.2 | 86.8 | 58.0 | NR | 41.8 | |
| Neutropenia | 57.3 | 91.5 | 49.5 | 65.2 | 51.7 | NR | 35.5 | |
| Thrombocytopenia | 47.3 | 76.3 | 53.8 | 83.3 | 52.2 | NR | 37.8 | |
| Non-hematologic (all grades) | ||||||||
| Rash | 70.6 | 96.8 | 36.8 | NR | NR | 34.4 | 61.8 | |
| Diarrhea | 72.3 | 84.5 | 48.5 | 22.7 | NR | 62.0 | 60.2 | |
| Stomatitis | 83.0 | 71.0 | 45.8 | 30.2 | NR | 69.0 | NR | |
| Non-hematologic (grade≥3) | ||||||||
| Rash | 81.6 | 78.6 | 41.8 | NR | NR | 36.8 | 60.8 | |
| Diarrhea | 63.67 | 94.2 | 26.5 | 72.0 | NR | 37.3 | 55.8 | |
| Stomatitis | 72.0 | 69.2 | 51.4 | 36.4 | NR | 71.0 | NR | |
Notes: SUCRA = surface under the cumulative ranking curves; NR = not report; A = Gemcitabine+Placebo; B = Gemcitabine+Axitinib; C = Gemcitabine+Trametinib; D = Gemcitabine+Sorafenib; E = Gemcitabine+Bevacizumab; F = Gemcitabine+Erlotinib; G = Gemcitabine+Tipifarnib.